Hung-Ju Chang

Principle Scientist at Xap Therapeutics

Hung-Ju Chang has a work experience starting from 2014 as a Postdoctoral Researcher at CBS Inserm. Recently, in 2022, Hung-Ju Chang has joined Xap Therapeutics as a Senior Scientist.

Hung-Ju Chang completed their Bachelor's degree in Agricultural Chemistry, specializing in Biochemistry, from National Taiwan University from 1997 to 2001. Hung-Ju then pursued a Master's degree in the Department of Agricultural Chemistry, Biochemistry division, at the same university from 2001 to 2003. Later, from 2007 to 2014, Hung-Ju Chang received their Doctor of Philosophy (PhD) from the Institute of Biochemical Sciences, College of Life Science, at National Taiwan University.

Location

Cambridge, United Kingdom

Links


Org chart

No direct reports

Teams


Offices


Xap Therapeutics

1 followers

Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs. Xap Therapeutics wasestablished in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.


Employees

11-50

Links